A Phase II study of M605106 for axillary osmidrosis

JRCT ID: jRCT2031200184

Registered date:06/11/2020

Basic Information

• Recruitment status: Complete
• Health condition(s) or Problem(s) studied: axillary osmidrosis
• Date of first enrollment: 02/10/2020
• Target sample size: 60
• Study type: Interventional
• Intervention(s): Apply an appropriate amount of investigational drug to the axilla twice daily and remove it after short time application.

Outcome(s)

• Primary Outcome: axillary odor scores
• Secondary Outcome: Adverse events, Laboratory test results

Key inclusion & exclusion criteria

• Age minimum: >= 20age old
• Age maximum: Not applicable
• Gender: Both
• Include criteria: axillary osmidrosis patients

Exclude criteria

(1)Not suitable for application of investigational drug from the viewpoint of safety, such as a wound on the axilla, or patients with complications or abnormal findings on the axilla affecting safety assessment.
(2)Patients judged by the investigator or sub-investigator to have a degree of odor(other than axillary odor) that may affect the evaluation of axillary odor.

Related Information

• Primary Sponsor: Infomation Trials Clinical